• Return to Headlines

Paratek Pharmace Shares Down 33.0% Since SmarTrend's Sell Call (PRTK)

By James Quinn

SmarTrend identified a Downtrend for Paratek Pharmace (NASDAQ:PRTK) on October 19th, 2017 at $22.85. In approximately 5 months, Paratek Pharmace has returned 33.04% as of today's recent price of $15.30.

In the past 52 weeks, Paratek Pharmace share prices have been bracketed by a low of $9.80 and a high of $29.00 and are now at $15.30, 56% above that low price. Over the past week, the 200-day moving average (MA) has gone down 1.4% while the 50-day MA has declined 0.3%.

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of antibiotics. The Company develops medicine for serious community-acquired bacterial infections. Paratek Pharmaceuticals products treat patients in both the community and hospital setting.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Paratek Pharmace.

Log in and add Paratek Pharmace (PRTK) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights paratek pharmace

Ticker(s): PRTK